VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RDY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RDYDr. Reddy's Laboratories Limited
$14.36$12.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRDYQuarterly Financials

Dr. Reddy's Laboratories Limited (RDY) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Dr. Reddy's Laboratories Limited (RDY) quarterly income statement — complete revenue, gross profit & net income history

RDY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22
Sales/Revenue76.33B87.27B88.05B85.45B85.06B83.59B80.16B76.73B70.83B72.15B832.2M67.38B765.6M67.7B790.11M52.15B722.59M53.2B777.86M49.19B
Revenue Growth %-10.26%4.41%9.84%11.37%20.09%15.85%9532.55%13.87%9151.62%6.57%5.33%29.2%5.95%27.26%1.57%6.02%11.39%7.91%18.15%11.36%
Cost of Goods Sold42.12B40.46B39.91B36.83B37.8B34.53B32.39B30.38B29.35B29.95B363.25M27.83B327.93M27.61B323.4M26.15B340.57M24.59B362.34M23.5B
COGS % of Revenue55.18%46.37%45.33%43.09%44.44%41.32%40.41%39.6%41.43%41.5%43.65%41.3%42.83%40.78%40.93%50.14%47.13%46.22%46.58%47.76%
Gross Profit34.22B46.81B48.14B48.63B47.26B49.05B47.77B46.34B41.48B42.2B468.95M39.55B437.67M40.09B466.71M26.01B382.01M28.61B415.52M25.7B
Gross Margin %44.82%53.63%54.67%56.91%55.56%58.68%59.59%60.4%58.57%58.49%56.35%58.7%57.17%59.22%59.07%49.86%52.87%53.79%53.42%52.24%
Gross Profit Growth %-27.61%-4.58%0.78%4.93%13.93%16.23%10086.48%17.17%9378.16%5.26%0.48%52.09%14.57%40.13%12.32%1.19%9.74%7.82%25.17%3.81%
Operating Expenses33.74B32.57B30.63B31.15B29.62B30.33B30.22B28.42B26.52B24.94B293.22M21.92B284M23.6B268.51M13.81B265.81M19.36B275.53M19.12B
OpEx % of Revenue44.2%37.32%34.78%36.46%34.82%36.29%37.7%37.04%37.45%34.56%35.23%32.53%37.09%34.86%33.98%26.49%36.79%36.38%35.42%38.87%
Selling, General & Admin28.19B26.92B26.44B23.18B24.05B24.12B23.01B22.69B20.48B20.23B227.34M0218.76M17.98B207.5M15.49B208.32M15.41B215.29M15.04B
SG&A % of Revenue36.94%30.85%30.02%27.13%28.28%28.85%28.7%29.57%28.91%28.04%27.32%-28.57%26.56%26.26%29.71%28.83%28.97%27.68%30.58%
Research & Development5.55B6.15B6.2B6.24B7.26B6.66B7.27B6.19B6.88B5.57B65.88M4.98B65.24M4.82B61.01M4.33B57.5M4.16B60.24M4.53B
R&D % of Revenue7.27%7.05%7.04%7.31%8.53%7.97%9.07%8.07%9.71%7.71%7.92%7.4%8.52%7.12%7.72%8.29%7.96%7.82%7.74%9.22%
Other Operating Expenses93-1000K-1000K1000K-1000K-1000K-1000K-1000K-1000K-1000K01000K01000K0-1000K0-1000K0-1000K
Operating Income473.25M14.24B17.51B17.48B17.65B18.72B17.55B17.93B14.96B17.27B175.72M17.64B153.67M16.43B198.2M12.21B116.2M9.23B139.99M6.61B
Operating Margin %0.62%16.32%19.89%20.45%20.75%22.4%21.89%23.36%21.12%23.93%21.12%26.17%20.07%24.26%25.09%23.42%16.08%17.36%18%13.43%
Operating Income Growth %-97.32%-23.94%-0.22%-2.51%17.97%8.41%9887.8%1.64%9634.42%5.13%-11.34%44.42%32.25%77.86%41.58%84.83%22.56%319.96%15.98%-18.5%
EBITDA6.14B19.29B22.56B22.24B22.2B23.44B21.53B21.73B18.67B21.04B221.55M21.2B192.46M19.7B237.37M15.26B155.53M12.21B180.28M9.51B
EBITDA Margin %8.04%22.1%25.63%26.03%26.1%28.04%26.85%28.33%26.36%29.16%26.62%31.47%25.14%29.09%30.04%29.26%21.52%22.95%23.18%19.34%
EBITDA Growth %-72.36%-17.71%4.82%2.32%18.9%11.42%9615.9%2.5%9601.92%6.81%-6.66%38.94%23.74%61.3%31.67%60.45%12.47%125.5%9.47%-15.43%
D&A (Non-Cash Add-back)5.66B5.05B5.05B4.76B4.55B4.72B3.98B3.81B3.71B3.77B45.83M3.57B38.79M3.27B39.17M3.05B39.33M2.98B40.29M2.9B
EBIT473.25M14.51B19.26B19.88B20.71B19.56B19.92B17.91B16.61B18.65B235.2M17.64B164.54M16.76B203.99M15B35.81M9.92B170.98M7.62B
Net Interest Income629.65M1.18B774M298M-92M-114M-92M146M54M189M366M-510.99K120M-145M-93M-130M859M47M3M16M
Interest Income1.7B2.13B1.68B1.13B564M704M665M744M647M583M719M4M474M273M216M217M1.18B262M237M209M
Interest Expense1.07B951.84M907M830M656M818M757M598M593M394M353M4.51M354M418M309M347M316M215M234M193M
Other Income/Expense1.55B1.19B837M1.57B2.41B22M1.62B896M1.06B990M55.71M827M7.49M-79M3.67M2.44B-83.2M474M31.16M818M
Pretax Income2.02B15.43B18.35B19.05B20.05B18.74B19.17B18.82B16.02B18.26B231.44M18.46B161.16M16.35B201.87M14.65B33M9.71B171.15M7.42B
Pretax Margin %2.65%17.68%20.84%22.29%23.58%22.42%23.91%24.53%22.61%25.3%27.81%27.4%21.05%24.14%25.55%28.1%4.57%18.25%22%15.09%
Income Tax-217.33M3.53B4.08B4.95B4.18B4.7B5.75B4.9B2.95B4.47B52.42M4.44B44.54M3.88B62.44M2.78B21.37M2.64B37.27M1.72B
Effective Tax Rate %-10.75%22.9%22.25%25.99%20.85%25.1%30.01%26.04%18.39%24.47%22.65%24.04%27.63%23.71%30.93%18.96%64.76%27.23%21.77%23.12%
Net Income2.24B12.1B14.37B14.18B15.94B14.13B12.55B13.92B13.07B13.79B179.01M14.03B116.62M12.47B139.43M11.88B11.63M7.07B133.89M5.71B
Net Margin %2.93%13.86%16.32%16.59%18.74%16.91%15.66%18.14%18.45%19.11%21.51%20.81%15.23%18.42%17.65%22.77%1.61%13.28%17.21%11.6%
Net Income Growth %-85.98%-14.4%14.49%1.85%21.94%2.49%6912.29%-0.75%11106.93%10.57%28.39%18.1%902.85%76.52%4.14%108.06%-76.61%3468.18%30.63%-1.47%
Net Income (Continuing)2.24B11.9B14.27B14.1B15.87B14.04B13.41B13.92B13.07B13.79B179.01M14.03B116.62M12.47B139.43M11.88B11.63M7.07B133.89M5.71B
Discontinued Operations00000000000000000000
Minority Interest3.33B3.39B3.59B3.7B3.78B3.84B3.94B0000000000000
EPS (Diluted)2.6814.5217.2517.0219.1016.9415.0516.6915.6716.5417.7684.2257.6074.9566.8971.405.2642.4859.6534.34
EPS Growth %-85.97%-14.29%14.62%1.98%21.89%2.42%-15.26%-80.18%-72.8%-77.93%-73.45%17.96%995.06%76.44%12.14%107.92%-84.2%3469.75%30.15%-1.49%
EPS (Basic)2.6814.5317.2717.0419.1316.9615.0616.6915.7016.5617.7984.3857.6075.0967.4071.565.2842.5859.8034.44
Diluted Shares Outstanding834.8M833.2M833.02M833.02M834.3M834.3M834.11M833.93M833.95M833.88M833.52M832.64M832.64M831.95M831.81M831.65M831.75M831.57M831.52M831.1M
Basic Shares Outstanding834.8M833.2M832.04M832.04M833.31M833.31M833.62M833.93M832.57M832.57M831.83M831.05M832.64M830.4M825.52M829.79M828.6M829.61M829.43M828.69M
Dividend Payout Ratio1.84%-46.33%---53.07%-0%0%3713.67%---3570.85%---3096.58%-